Remove 2015 Remove Healthcare Remove Leads
article thumbnail

Employee Spotlight: Meghan Oates

InCrowd

My team and I highlight customer value, drive lead generation, support sales, and stimulate client utilization of both commercial solutions, as well as demonstrate InCrowd and SHG’s combined value through Apollo Advantage initiatives. I’d been in healthcare most of my career but not specifically pharma or market research.

Marketing 147
article thumbnail

The White House Climate Pledge: Why Sustainability Makes Good Business Sense in Healthcare

PM360

The White House’s recent Health Sector Climate Pledge brought together hospitals and healthcare companies that committed to reduce greenhouse gas emissions 50% by 2030. The social, economic, and environmental impact of such initiatives are clear, but only a few companies in the healthcare industry have made this kind of commitment so far.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

article thumbnail

Novel haemophilia B gene therapy approved

European Pharmaceutical Review

This means that patients with the rare genetic bleeding disorder can produce FIX themselves instead of relying on regular intravenous infusions of FIX, which is the current standard of care, according to 2015 research highlighted by Pfizer. This authorisation of BEQVEZ is based on results from the pivotal Phase III BENEGENE-2 study.

article thumbnail

Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

pharmaphorum

Angela is working to ensure the UK life sciences sector expands its footprint as a priority country for inward investment in research and medicines launch as healthcare ecosystems recover from the impact of COVID-19. Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England.

Medicine 122
article thumbnail

Healthcare Industry Leaders and Workplace Equity Champions Announced as 2023 Award Recipients by the Healthcare Businesswomen’s Association

Pharma Marketing Network

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

article thumbnail

Chiesi expands rare disease portfolio with Amryt Pharma acquisition

pharmaphorum

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 on 6 th January.

Pharma 98